Turning Inventions into Innovations
Services
Drug Discovery
-
Structure-based drug design
-
Hit identification and validation
-
Hit to lead/lead optimization
-
Candidate selection criteria
Preclinical Development
-
Global CRO selection and management
-
Salt screening/salt selection
-
Physicochemical and solid state characterization
-
Non-GMP scale up and labelled-API for toxicology and bio-distribution evaluation
-
Preformulation and formulation development
Business Strategy
-
Development and research strategy
-
Preparation and review of scientific content for investor pitch decks, preliminary prospectus
-
Draft and review CDAs, NDAs, master service agreements, research partnership agreements
-
Scientific due diligence of companies for research or M&A opportunities
Chemistry, Manufacturing and Controls (CMC)
-
Global CMO selection and management
-
Drug substance and drug product stability protocols
-
Analytical method development and fit-for-purpose validation
-
cGMP drug substance and drug product manufacturing for Phase 1 and Phase 2
-
Preparation and review CMC documentation for both FDA and Health Canada regulatory filings
Intellectual Property
-
Competitive landscape analysis
-
Draft and review of scientific content for patent filings
Areas of Expertise
Therapeutic Areas
-
Oncology
-
Antimicrobials
-
Inflammation
-
Rare diseases-nephrology & dermatology
-
Oral and topical medical cannabis product design and development
Chemistry
-
Natural products
-
Heterocyclic chemistry
-
Asymmetric chemistry
-
Nucleosides and Nucleotides
-
Peptides
-
CRISPR/Cas gene editing
Drug Targets
-
Kinases
-
Methyltransferases
-
G-protein coupled receptors (GPCRs)
-
Endocannabinoid system
-
Rare monogenic disorders